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Objectives   This study investigated the associations between occupational exposures to solvents and metals and 
fixed airflow obstruction (AO) using post-bronchodilator spirometry.
Methods  We included 1335 participants from the 2002–2008 follow-up of the Tasmanian Longitudinal Health 
Study. Ever-exposure and cumulative exposure-unit (EU) years were calculated using the ALOHA plus job 
exposure matrix (JEM). Fixed AO was defined as post-bronchodilator forced expiratory volume in one second 
(FEV1)/forced vital capacity (FVC) <0.7 and FEV1/FVC<lower limit of normal. Diffusing capacity of the lung 
for carbon monoxide (DLCO) was combined with FEV1/FVC<0.7 to define fixed AO plus low DLco. Multinomial 
regressions were used to estimate associations adjusting for possible confounders.  
Results  Ever-exposure to metals was associated with fixed AO [relative risk (RR) 1.71, 95% CI 1.03–2.85] 
and fixed AO lower limit of normal (RR 1.67, 95% CI 1.00–2.78). Women had lower cumulative EU years to 
chlorinated solvents [mean 20.9, standard deviation (SD) 13.4] than men (mean 28.6, SD 36.9). However, the risk 
of developing fixed AO and fixed AO plus low DLCO associated with each cumulative EU year of chlorinated sol-
vents were higher among women than men (RR 1.08 versus 0.99, P-value for effect measure modification=0.006; 
RR 1.08 versus 1.00, P-value for effect measure modification=0.02).  
Conclusions   We have shown ever-exposure to metals and chlorinated solvents are important risk factors for 
fixed AO. The effects for solvents were strongest among women. Preventive strategies need to be followed to 
reduce these exposures at the workplace.     
Key terms   ALOHA; chlorinated solvent; chronic obstructive pulmonary disease; COPD; JEM; job exposure 
matrix. 
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Exposure to solvents and metals and fixed airflow obstruction
A number of studies have identified that exposures to 
solvents (1–4) and metals (5) can influence respiratory 
symptoms. However, only a few have investigated these 
exposures in relation to fixed airflow obstruction (AO) 
that is used to define chronic obstructive pulmonary 
disease (COPD)  in epidemiological literature (6, 7).  
 Solvents are routinely used in industry and are pres-
ent in products such as fuels, paints, printing, degreas-
ing metal parts, and cleaning products (8, 9). Solvents 
can be further divided into “aromatic solvents” such as 
benzene and “chlorinated solvents” including trichloro-
ethylene, and tetrachloroethylene (4, 9). On inhalation, 
solvents slowly damage the airways causing mucus 
hypersecretion and may subsequently lead to airflow 
obstruction (10). Population-based studies have sug-
gested a link between occupational exposure to solvents 
and chronic nonspecific lung disease (1–3, 11) and 
reduced lung function using pre-bronchodilator (BD) 
spirometry (4, 11). However, their findings are limited 
by their reliance on self-reported exposure and the use 
of physician’s diagnosis to define chronic nonspecific 
lung disease. The Dutch Life Lines Cohort Study found 
an association between chlorinated solvents and chronic 
mucus hypersecretion in participants without AO (7), 
but no association between chlorinated solvents and 
lower lung function and AO (6). Limitations of these 
studies included the use of pre-BD to define AO when 
the recommended criterion is post-BD (12) and the use 
of current job rather than a complete job history which 
allows assessment of cumulative exposure (13).
Metals are also commonly used in a variety of 
industrial processes (14) and, via the manipulation of 
metal products, metal form aerosols can be inhaled (15). 
Population-based studies have suggested an association 
between occupational exposure to metals and chronic 
nonspecific lung disease (1, 7). Only two population-
based studies have assessed the relationship between 
metals exposure and AO defined using lung function 
measurements, and neither found a significant associa-
tion (4, 7). However, these studies were again limited by 
the use of pre-BD spirometry to define AO.
We investigated the associations between exposures 
to solvents and metals and fixed AO defined by post-
BD spirometry and used a general population-based job 
exposure matrix (JEM) to calculate ever-exposure and 
cumulative exposure-unit (EU) years.
Methods
Data collection
Our study included participants from the most recent 
laboratory phase of the Tasmanian Longitudinal Health 
Study (TAHS) for which the methodology has been 
reported previously (16). In brief, the TAHS began in 
1968 when 8583 Tasmanian children born in 1961 and 
attending school in Tasmania were enrolled by their par-
ents who completed a respiratory health questionnaire 
for the child, who then underwent clinical examinations 
and lung function measurements. Data for the current 
analysis were collected at the follow-up survey started in 
2002 (figure 1). The follow-up began with tracing 7562 
(88.1%) of the original 1968 cohort to an address and 
achieving a response of 5729 (78.4%) to a postal survey 
(16). A subgroup of these respondents, selected on the 
basis of their participation in previous follow-ups, and 
an enriched sample with a history of asthma and chronic 
bronchitis were invited to participate in a detailed labo-
ratory study between 2005 and 2008. Of the 2387 indi-
viduals invited, 1397 (58.6%) attended the laboratory and 
completed lung-function testing, 354 (14.8%) completed 
a telephone questionnaire including lifetime work history 
calendar but did not attended the laboratory to complete 
lung-function testing and remaining 636 (26.7%) with-
drew. At the laboratory visit, participants completed 
a detailed interviewer-administered respiratory health 
questionnaire, completed a lifetime work history calendar, 
performed pre- and post-BD lung-function tests, skin-
prick testing, lung volumes, and diffusing capacity test.
Lung-function testing 
Pre and post-BD lung function were measured using the 
Easyone Pro® ultrasonic spirometer (ndd, Medizintech-
nik, AG, Switzerland). Participants were asked not to 
smoke for 4–6 hours before testing. Forced expiratory 
volume in one second (FEV1) and forced vital capacity 
(FVC) were measured according to the American Tho-
racic Society (ATS) and European Respiratory Society 
(ERS) joint statement (17) and the highest value for 
FEV1 and FVC was recorded from three acceptable and 
repeatable tests. Spirometry was repeated 10–15 minutes 
after short-acting bronchodilator (200 μg salbutamol) 
administered via a spacer. 
Single breath diffusing capacity of the lung for 
carbon monoxide (DLCO) was measured according to 
international guidelines and adjusted to a standard 
haemoglobin concentration of 14.6 g/dL in men and 
13.4 g/dL in women and corrected for the presence of 
carboxyhemoglobin (18). The average of two acceptable 
tests that agreed to within 10% was recorded. Predicted 
values of DLCO were calculated using the prediction 
equations of Thompson and colleagues (19). 
Lung-function definitions
Fixed AO was defined in two ways: first, according to 
the Global Initiative for Chronic Obstructive Lung Dis-
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ease (GOLD) fixed cut-off criterion (FEV1/FVC<0.7) 
(20) and second using FEV1/FVC<lower limit of normal 
(LLN) as based on the Global Lung Initiative (GLI) 
2012 reference equations (21). 
Fixed AO plus low DLCO was defined by FEV1/
FVC<0.7 and DLCO <80% of predicted value (22).
Occupational exposures
Occupational exposure were classified based on a full 
job history that was completed during the laboratory 
visit or telephone interview. Participants were asked to 
list all the jobs held over their lifetime. We collected 
data including job title, industry type, company name, 
the year when job started and ended from 1599 par-
ticipants. In this analysis, we included 1335 participants 
those have both work history calendar and completed 
lung-function testing at the 2002–2008 follow-up. The 
jobs reported in the calendars were coded according to 
the International Standard Classification of Occupa-
tions (ISCO-88) four- digit classification (23). These 
codes were then used to assign occupational exposures 
to solvents (three categories: aromatic solvents, chlori-
nated solvents, and other solvents) and metals using the 
ALOHA plus JEM (6, 24). The JEM classified subjects 
based on job code into no, low and high exposure.  
Ever-exposure. We combined low and high exposure 
categories – because the small number of partici-
pants in the high-exposed group limited the statistical 
analysis – and assigned people as "ever exposure", if 
they had occupational exposure for any job over their 
working life (25). 
Cumulative EU years. We estimated this by the number 
of years worked in a given job multiplied by the expo-
sure intensity for the given job and summed for each 
individual and each exposure across all jobs performed. 
To allow for the combination of low and high exposure 
categories, years of exposure was weighted by four for 
high exposure and one by low exposure to calculate 
cumulative EU years (24).
Statistical methods
All the statistical analyses were performed using Stata 
13.1 (Stata Corporation, College Station, TX, USA) 
statistical package. Multinomial logistic and linear regres-
sion models were used to analyzed the associations 
between occupational exposures and fixed AO (categori-
cal) and lung-function measures (continuous). The lung 
function variables were normally distributed. The final 
multinomial model was adjusted for sex, smoking, pack-
years, asthma in childhood and adulthood, and socio-
economic status in childhood and adulthood (see online 
supplementary material for details, www.sjweh.fi/index.
php?page=data-repository). Sampling weights were 
derived by calculating the inverse probability of selection 
for the enriched sample of the 2002 to 2008 follow-up.
To investigate potential effect measure modification 
by sex, smoking, and current asthma, additive log risk 
model were compared with multiplicative risk ratio 
model using likelihood ratio test and Bayesian infor-
mation criterion. We did not identify any effect mea-
sure modification between occupational exposure and 
smoking or current asthma status (results not shown). 
However, we did observe some effect measure modi-
fication with sex so results for the association between 
cumulative EU years and fixed AO are stratified by sex. 
We excluded the participants with missing or incomplete 
years started or ended (N=80) from the cumulative EU 
years analysis. All complete case analysis were addition-
ally compared with multiple imputation for dealing with 
missing data (data not shown). A cut-off of P<0.05 was 
considered as statistically significant.  
We examined the correlation between solvents and 
metals exposure with other exposures from the ALOHA 
plus JEM; vapors, gases, dust, and fumes (VGDF) and 
all pesticides exposures and did not see a strong corre-
lation between any of these variables (data not shown). 
Additionally, in our final adjusted regression model, we 
included VGDF, and pesticides exposures as an addi-
tional confounder to observe if they changed the effect 
estimates. As the addition of these variables into the 
models did not change in the effect estimates by 10% 
or more (data not shown), we did not adjust our final 
models for these factors. 
Results
The characteristics of the study population are presented 
in table 1. The mean age of participants was 44.8 years, 
and more than half (51.6%) were men. Men had a higher 
median smoking pack-years than women (table 1) and 
25% men were current smokers, compared with 18% of 
women. A comparison of non-responders to different 
parts of the 2002 to 2008 follow-up study is shown in 
supplementary table S1. Briefly selected characteristics 
of the participants who did and did not attend labora-
tory were similar. Men were more likely to have had 
ever occupational exposure to solvents and metals than 
women (supplementary table S2).
Ever-exposure
Ever-exposure to chlorinated solvents was associated 
with an increased risk of fixed AO [relative risk (RR) 
1.45, 95% CI 0.91–2.34] and fixed AO plus low DLCO 
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(RR 2.19, 95% CI 0.98–4.91) with both approachings 
but not quite reaching statistical significance (table 2). 
Ever-exposure to metals was also significantly associ-
ated with an increased risk of fixed AO (RR 1.71, 95% 
CI 1.03–2.85) but the evidence for its association with 
of fixed AO plus low DLCO was modest (RR 2.04, 95% 
CI 0.83–5.04).
We also investigated the association between ever-
exposure to aromatic solvents, chlorinated solvents, 
other solvents, metals and lung function measures 
(FEV1, FVC, FEV1/FVC, and DLCO) (supplementary 
table S3). We found significant association with lower 
FEV1/FVC ratio for those with ever-exposure to metals 
(z-score FEV1/FVC ratio; -0.17, 95%CI -0.33– -0.02), 
but we found no other significant associations (supple-
mentary table S4).
We found the similar association between ever 
exposed to metals and pre-BD FEV1/FVC<0.7 (RR 
1.47, 95% CI 1.00–2.21) and FEV1/FVC<LLN (RR 
1.57, 95% CI 1.04–2.39) (supplementary table S5). 
Additionally, we found a significant association with 
other solvents (RR 1.39, 95% CI 1.00–1.93) and pre-BD 
airflow obstruction. 
Effect measure modification and cumulative EU-years 
We examined effect measure modification by sex, asthma 
status, and smoking status. We presented the associations 
between cumulative EU years and fixed AO and fixed 
AO plus low DLCO stratified by sex in table 3. We found a 
significant effect measure modification between sex and 
cumulative EU years to chlorinated solvents on the risk 
of fixed AO-GOLD and fixed AO-LLN. We found women 
have less cumulative EU years to chlorinated solvents 
[mean 20.9, standard deviation (SD) 13.4] compared to 
men (mean 28.6, SD 36.9), but women have modified 
the association between cumulative EU years to chlori-
nated solvents and fixed AO-GOLD and fixed AO-LLN 
(RR 1.08, 95% CI 1.03–1.15) than men. Figures 1 and 
2 displays the predicted probabilities of fixed AO that 
were computed using the estimates from the multivariate 
regression models. In this model, women with increasing 
chlorinated solvent EU years had a significantly increased 
risk of fixed AO. However, for men, we did not observe 
any such relationship. We observed a similar effect mea-
sure modification by sex for fixed AO plus low DLCO 
(P-value for effect measure modification=0.02, figure 3). 
Table 1. Study characteristics stratified by sex. [SD=standard deviation; IQR=interquartile range; GOLD=global initiative for chronic 
obstructive lung disease; LLN=lower limit of normal; DLCOdiffusing capacity of the lung for carbon monoxide.]
Study characteristics Total (N=1335) Men (N=684) Women (N=651) P-value 
N % Mean SD Pack-years N % Pack-years N % Pack-years
Median IQR Median IQR Median IQR
Age 44.8 0.8 0.01
Never smokers 566 45.2 292 44.4 274 46.3
0.47Past smokers 395 29.7 7.7 2–17.3 189 28.4 9.8 2.1–19 205 30.9 5.5 1.5–15
Current smokers 370 21 25.0 22.4–27.9 202 25 25 13.8–35 168 18 18 7.8–27
Fixed AO-GOLD 113 6.0 70 7.2 43 4.8 0.01
Fixed AO-LLN 112 6.0 69 7.1 43 4.8 0.02
Fixed AO plus low DLCO 35 1.7 19 1.9 16 1.5 0.76
Adult asthma 649 28.9 313 26.0 336 32.1 0.03
Child asthma 382 15.3 221 17.2 161 13.3 0.01
Table 2. Associations between ever-exposures, fixed airflow obstruction (AO) and fixed AO plus low diffusing capacity of the lung for 
carbon monoxide (DLCO). [GOLD=global initiative for chronic obstructive lung disease; LLN=lower limit of normal; RR=relative risk.]















Not exposed 873 70 Ref. 873 70 Ref. 827 24 Ref.
Exposed 349 43 1.21 0.76–1.93 350 42 1.18 0.74–1.88 338 11 0.91 0.39–2.12
Chlorinated solvents
Not exposed 964 78 Ref. 964 78 Ref. 914 23 Ref.
Exposed 258 35 1.45 0.91–2.34 259 34 1.40 0.87–2.28 251 12 2.19 0.98–4.91
Other solvents
Not exposed 749 58 Ref. 749 58 Ref. 710 19 Ref.
Exposed 473 55 1.34 0.89–2.06 474 54 1.32 0.87–2.02 455 16 1.24 0.60–2.57
Metals
Not exposed 948 72 Ref. 948 72 Ref. 898 22 Ref.
Exposed 274 41 1.71 1.03–2.85 275 40 1.67 1.00–2.78 267 13 2.04 0.83–5.04
a Adjusted for sex, smoking, pack-years, childhood and adulthood socioeconomic status, and childhood and adulthood asthma .
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We did not observe that sex modifed the effect of other 
exposures or any effect modification by sex, smoking 
or asthma status for exposures to either solvents or met-
als and fixed AO. Sex did not modify any associations 
between any of the solvents or metals and AO when 
defined using pre-BD lung function (data not shown).
Discussion
Our study is the first to assess occupational exposures 
to solvents and metals examining both ever-exposure 
and cumulative EU years in this cohort. The major new 
finding is that increasing cumulative EU years to chlori-
nated solvents is significantly associated with increased 
risks of fixed AO for women but not men although mean 
cumulative EU years to chlorinated solvents was less 
among women. The observed associations with fixed 
AO were restricted to the cumulative EU years and not 
ever being exposed to aromatic, chlorinated, and other 
solvents. However, we did find that ever-exposure to 
metals was associated with fixed AO and a lower FEV1/
FVC ratio, but no association was observed with cumu-
lative EU-years to metals. 
To our knowledge, ours is the first study to show 
Table 3. The association between cumulative exposure-unit (EU) years and fixed airflow obstruction (AO) and fixed AO plus low low dif-
fusing capacity of the lung for carbon monoxide (DLCO). stratified by sex and adjusted for smoking, pack-years, childhood and adulthood 
socioeconomic status, and childhood and adulthood asthma. [GOLD=global initiative for chronic obstructive lung disease; LLN=lower limit 
of normal; RR=relative risk; SD=standard deviation.]
Exposure Women Men P-value a 
N Cumulative EU years RR 95% CI N Cumulative EU years RR 95% CI
Mean SD Mean SD
Aromatic solvents
Fixed-AO-GOLD         
No 559 7.1 6.9 Ref 589 17.4 16.6 Ref
Yes 39 38.3 57.1 1.02 0.98–1.07 68 13.4 11.2 0.99 0.97–1.01 0.17
Fixed-AO-LLN              
No 559 7.1 6.9 Ref 590 17.5 16.6 Ref
Yes 39 38.3 57.0 1.03 0.99–1.07 67 12.7 10.5 0.99 0.97–1.01 0.14
Fixed AO + low DLCO  
No 514 6.6 6.1 Ref 579 17.1 16.5 Ref
Yes 14 38.3 57.0 1.05 0.98–1.14 18 17.5 10.9 0.99 0.95–1.03 0.05
Chlorinated solvents
Fixed-AO-GOLD         
No 559 8.1 6.7 Ref 589 40.9 40.4 Ref
Yes 39 20.9 13.4 1.08 1.03–1.15 68 28.6 36.9 0.99 0.98–1.00 0.006
Fixed-AO-LLN              
No 559 8.1 6.7 Ref 590 40.7 40.4 Ref
Yes 39 20.9 13.4 1.08 1.03–1.15 67 29.3 37.4 0.99 0.98–1.00 0.006
Fixed AO + low DLCO 
No 514 8.8 8.2 Ref 579 38.4 39.5 Ref
Yes 14 23.7 5.3 1.08 1.01–1.17 18 47.3 47.7 1.00 0.99–1.02 0.02
Other solvents
Fixed-AO-GOLD         
No 559 16.5 17.2 Ref 589 17.8 18.0 Ref
Yes 39 19.1 19.9 1.01 0.99–1.03 68 12.5 10.0 0.99 0.97–1.01 0.17
Fixed-AO-LLN              
No 559 16.6 17.2 Ref 590 18.1 18.4 Ref
Yes 39 18.9 19.2 1.01 0.99–1.03 67 11.6 9.2 0.98 0.96–1.00 0.12
Fixed AO + low DLCO
No 514 17.0 17.6 Ref 579 17.5 17.9 Ref
Yes 14 21.0 27.3 1.02 0.99–1.04 18 17.6 10.1 0.99 0.96–1.02 0.27
Metals
Fixed-AO-GOLD         
No 559 9.3 11.5 Ref 589 34.4 38.3 Ref
Yes 39 27.0 22.5 1.05 0.98–1.12 68 24.1 33.4 0.99 0.99–1.00 0.17
Fixed-AO-LLN              
No 559 9.3 11.5 Ref 590 34.3 38.3 Ref
Yes 39 27.0 22.5 1.05 0.98–1.13 67 24.4 33.8 0.99 0.99–1.00 0.17
Fixed AO + low DLCO 
No 514 12.1 14.3 Ref 579 32.1 37.1 Ref
Yes 14 20.5 27.6 0.87 0.39–1.94 18 38.7 46.8 1.00 0.99–1.02 0.58
a Likelihood ratio P-value for risk ratio modification between cumulative EU-years and sex.
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that cumulative EU years to chlorinated solvents is 
associated with fixed AO and fixed AO plus low DLCO 
in women. The only study that assessed the association 
between ever- (low or high) exposure to chlorinated 
solvents and AO was limited to pre-BD lung function 
measures, which do not allow for clarifying the fixed 
nature of the airflow obstruction (6). However, similar 
to the LifeLines Cohort Study, we did not find any asso-
ciation between chlorinated solvents and AO defined 
using pre-BD airflow obstruction (6) nor any an effect 
modification by sex. 
The different job distribution between men and 
women in our study may be another reason for increased 
risk among women. In our study, women exposed to 
chlorinated solvents worked as dry cleaners, laundry 
pressers, sculptors, painters, decorators and commer-
cial designers, chemist, hairdresser or beauticians and 
chemical laboratory science technicians, while men were 
mostly metal, rubber, plastic product assemblers, glass, 
ceramics painters, mechanical and electrical technicians, 
painters, and sheet metal workers. Exposure to specific 
types of chlorinated solvents has been associated with 
symptoms of cough and phlegm in female laundry 
employees and dry cleaners (26). One might speculate 
that the increased risk of airflow obstruction among 
women who had occupational exposure to chlorinated 
solvents in our study might be related to an increased 
number for women to work in jobs with exposure to 
chlorinated solvents such as in the dry-cleaning or paint-
ing or pharmaceuticals industries. However, we actually 
found the women in our study had a lower prevalence of 
exposure and had fewer years of cumulative exposure to 
chlorinated solvents than men had. This raises the pos-
sibilities that the observed association could be related 
to the different types of chlorinated solvents used in 
different jobs undertaken by men and women, or alter-
natively, a greater degree of susceptibility to chlorinated 
solvents in women. 
A greater susceptibility for women to develop 
fixed AO from inhaling respiratory pollutants has been 
debated over past decades (27). Postulated mechanisms 
include more toxin being deposited per surface area of 
the lungs, impaired clearance of the toxin substance 
or a modified biological response to the inhaled toxin 
(27, 28). Evidence from studies of smoking has shown 
that women receive a greater dose of toxin for the same 
amount of inhaled smoke because of their smaller air-
way size (29). Toxins in the airways are metabolized 
via the cytochrome P450 pathway (27). The female sex 
hormone estrogen can influence this pathway by causing 
the up-regulation of the CYP1A1, CYP1A2, CYP2A6, 
CYP3A4, and CYP1B1 cytochromes (28, 30). The role 
of these enzymes in the toxin metabolism pathway leads 
to increased oxidation of inhalation leading to increased 
oxidative stress in the airways and greater risk of airflow 
 
Figure 1. The associations between years of chlorinated solvents 
exposure and probability of fixed AO-GOLD, stratified by sex. Circles 
represent the probability of the outcome (fixed AO), and the bars rep-
resent the 95% confidence interval of that probability.
 
Figure  2. The association between years of chlorinated solvents exposure 
and probability of fixed AO-LLN, stratified by sex. Circles represent the 
probability of the outcome (fixed AO), and the bars represent the 95% 
confidence interval of that probability.
 
Figure 4. The association between years of chlorinated solvents expo-
sure and probability of fixed AO plus low DLco, stratified by sex. Circles 
represent the probability of the outcome (fixed AO plus low DLco), 
and the bars represent the 95% confidence interval of that probability.
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obstruction in women (28). A recent in vivo animal study 
in mice suggested that female mice were more suscep-
tible to airway remodeling with narrowed airway lumens 
and thickened airway walls compared to men, which 
they hypothesized was due to a greater susceptibility 
to oxidative stress due to the presence of the female 
sex hormone, estrogen (31). Studies among humans 
conflict with one study by Matheson et al (24) that 
found an increased risk of airflow obstruction among 
women exposed to biological dust but no increased risk 
among men. In contrast, some previous studies have 
assessed occupational exposure among men and women 
separately and have not observed any differences by 
sex (32, 33). A possible reason for this difference could 
that the latter two studies used pre-BD spirometry, and 
their study participants were younger and therefore less 
likely to have developed fixed AO. Importantly, none of 
these studies investigated chlorinated solvents exposure, 
and it may be that the chemical structure of chlorinated 
solvents increases the risk among women but not men. 
Overall, our findings add to the limited body of evidence 
that supports women as being more susceptible to the 
adverse lung function effect from specific occupational 
exposures.
Along with fixed AO, we also found an increased 
risk of fixed AO plus low DLCO with increasing cumula-
tive EU years to chlorinated solvents. Coexistent low 
DLCO indicates the presence of emphysema as a diagnosis 
of emphysema requires either radiological evidence on 
computed tomography scan or a reduced gas transfer 
factor in the presence of chronic airflow obstruction 
(22). Others have also shown that some other occupa-
tional exposures have been associated with pulmonary 
emphysema at autopsy (34) or detected by computed 
tomography imaging (35). To our knowledge, no previ-
ous study has assessed the association between chlo-
rinated solvents and emphysema. One previous study 
that used this definition of asymptomatic emphysema 
(airflow obstruction plus low DLCO) found women with 
biological dust exposure were at an increased risk of 
emphysema (24). However, as we combined the defini-
tion of fixed AO with low DLCO, there is a chance that 
the participants with fixed AO may have influenced or 
contributed in the combination of the two outcomes 
rather than gas transfer factor itself. 
Ever-exposure to metals was associated with lower 
level of FEV1/FVC and a greater risk of fixed AO in 
our study, and this is consistent with previous studies 
that found an increased risk of respiratory symptoms 
(7) and lung function decline (5, 36, 37) with exposure 
to metals in welders. For steelworkers, cumulative 
respirable metal dust exposure may cause pulmonary 
surfactant impairment resulting in lung function decline 
and chronic respiratory diseases (5). Subjects exposed 
to metals in our study were mainly working in metal or 
steel industries such as motor vehicle mechanics and 
fitters, sheet metal worker, welders and flame cutters 
and agriculture or industrial machinery mechanics. Our 
observation of an association between ever-exposure 
to metals was similar to previous studies that found 
an association between any exposure (high or low) to 
metals with lung function and chronic lung disease (1, 
4, 7). However, due to lack of lifetime work history cal-
endar, previous studies were unable to assess cumulative 
exposure (1, 4, 7). 
The major strengths of our study include the use 
of post-BD spirometry to define fixed AO, the avail-
ability of lifetime work histories for the participants’ 
entire working life, the use of a general population 
-based ALOHA plus JEM and adjustment for important 
potential confounding factors collected prospectively 
over time. The lifetime work histories allowed us to 
calculate ever and cumulative EU years and reduces the 
chance of recall bias as the participant is asked to recall 
their entire work history not just jobs they may recall as 
having high exposure to a possible causative agent. The 
main limitations of our study include possible sources 
of information bias, including recall and misclassifica-
tion bias, and selection bias such as non-response bias. 
There is the possibility of recall or "exposure suspi-
cion" bias caused by the participant’s selective recall 
of exposures. We have at least reduced the possibility 
of this type of bias using a JEM based on lifetime work 
history calendars that collected information on all jobs 
the participant has ever held irrespective of the possi-
bility of exposure. JEM themselves may be affected by 
non-differential misclassification bias of the exposure 
due to the heterogeneity of exposure within a given job 
title or occupation, but, if present, such non-differential 
misclassification would be expected to underestimate the 
true effects of exposure. Furthermore, the interviewing 
staff and participants were blinded to the occupational 
exposure hypothesis reducing the possibility of informa-
tion biases. The next possible type of bias in our study 
is selection or non-response bias or "healthy volunteer" 
bias, caused by the participants choosing to participate 
in the laboratory study. Participants who self-select to 
participate in a study have in general better health than 
those who do not. We cannot fully exclude this type of 
bias however we did adjust all analysis for factors found 
to differ between those who attended the laboratory 
and those who did not. Based on these limitations, we 
suggest that our results should be viewed as hypothesis-
generating rather than proof that these exposures are 
causal and replication in another cohort is needed.
In conclusion, our study has shown that cumulative 
EU years to chlorinated solvents is associated with 
increased risk of post-BD fixed AO among women but 
not men. We have also shown that this association is not 
due to greater exposure of women and suggest that this 
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may be due to their greater susceptibility. We also found 
that ever-exposure to metals was associated with fixed 
AO. Our study emphasizes the need to utilize post-BD 
spirometry to define fixed AO which allows adequate 
consideration of asthma, especially for a middle-aged 
population. Our findings highlight the need to reduce 
workplace exposure to solvents and metals by eliminat-
ing the source of exposure origin, improving adher-
ence to use of recommended protective equipment, 
and workplace monitoring of exposure levels could be 
implemented. Preventive measures and exposure control 
strategies could be linked to periodic workplace risk 
assessment of the exposure in the relevant industries. 
By enhanced follow-up to and use of protective equip-
ment, the burden of fixed AO caused by occupational 
exposures has the potential to be substantially reduced. 
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